Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism (Q44000084)

28 November 2017

title

Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism (English)

1 reference

28 November 2017

0 references

1 reference

Y Yu

1

1 reference

28 November 2017

P H Correll

series ordinal

2

1 reference

28 November 2017

J P Vanden Heuvel

series ordinal

3

1 reference

28 November 2017

publication date

1 April 2002

1 reference

Biochimica et Biophysica Acta

28 November 2017

published in

1 reference

28 November 2017

volume

1581

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

89-99

1 reference

Conjugated linoleic acid (9,11- and 10,12-octadecadienoic acid) is produced in conventional but not germ-free rats fed linoleic acid

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Survey of the conjugated linoleic acid contents of dairy products.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Conjugated linoleic acid and atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Peroxisome proliferator-activated receptors: a critical link among fatty acids, gene expression and carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

PPAR Tissue Distribution and Interactions with Other Hormone-Signaling Pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Differential activation of adipogenesis by multiple PPAR isoforms.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Terminal differentiation of human breast cancer through PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Different mechanisms in inhibition of rat macrophage nitric oxide synthase expression by FK 506 and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Absolute quantification of target DNA: a simple competitive PCR for efficient analysis of multiple samples

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Role of interferon gamma and tumour necrosis factor alpha in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

CLA reduces antigen-induced histamine and PGE(2) release from sensitized guinea pig tracheae

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Conjugated linoleic acid and bone biology

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Activation of PPARgamma may mediate a portion of the anticancer activity of conjugated linoleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Rel/NF-kappa B and I kappa B proteins: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

Activation of immediate-early gene expression by peroxisome proliferators in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2802%2900126-9

7 January 2021

10.1016/S1388-1981(02)00126-9

Identifiers

DOI

0 references

1 reference